Join our journey towards a better future
Discover the latest news, events, and updates on our collaborative endeavors. Stay informed about our ongoing work, upcoming events, and progress toward our shared goals. Embracing inclusivity, we unite partners from diverse sectors and disciplines to collectively shape the future.
New clinical study will provide more cancer patients with targeted treatment
FOCU.SE is a new Swedish study in which genetic analysis of tumours is used to match cancer patients with targeted drugs outside of approved indication. The aim is to give more people access to effective treatment, while gathering valuable knowledge for the future.
FOCUSE - The Swedish Precision Cancer Medicine Trial
FOCUSE is an initiative by Testbed Sweden Precision Health Cancer, founded by Vision Zero Cancer, Genomic Medicine Sweden and SciLifeLab, involving regulators, policymakers, payers, researchers, healthcare providers, patient advocates, and industry to drive the implementation of precision health in cancer care.